Article Per Year (5 Year)
p-Index From 2020 - 2025
0.408
P-Index
This Author published in this journals
All Journal JFL : Jurnal Farmasi Lampung
Tri Wahyuni, Novita
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Chemistry Immunology & microbiology Medicine & Pharmacology Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Hubungan Tingkat Pengetahuan Dengan Perilaku Pengobatan Acne Vulgaris Di Kalangan Pelajar Sman 4 Bandar Lampung Tri Wahyuni, Novita; Sari, Novita; Allesia, Eci
JFL : Jurnal Farmasi Lampung Vol. 12 No. 2 (2023): JFL : Jurnal Farmasi Lampung
Publisher : Program Studi Farmasi-Fakultas Matematika dan Ilmu Pengetahuan Alam-Universitas Tulang Bawang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37090/jfl.v12i2.1208

Abstract

Acne vulgaris (AV) is a condition when the skin pores become clogged and cause the appearance of pus sacs on the skin causing inflammation. In general, Acne vulgaris is a teenage skin disease that most often occurs at the age of 15-18 years. The purpose of this study was to determine the relationship between the level of knowledge and acne vulgaris treatment behavior among adolescents of SMAN 4 Bandar Lampung. The type of research conducted is descriptive, analytical, cross-sectional with instruments in the form of questionnaires. The sample in this study was students of SMAN 4 Bandar Lampung. The sampling technique was carried out by random sampling with a total of 90 respondents in accordance with the inclusion criteria. Data analysis in this study used Chi-square testing techniques. The results of this study showed that the number of respondents with the female sex (74%) was more than men (26%), this result showed that women experienced acne vulgaris more often than men. and respondents experienced acne vulgaris the most at the age of 15 years (30%). The results showed the level knowledge of respondentd (54%) in yhe good category, while the level of respondent behavior (54%) in the medium category. The results of the correlation analysis test showed a relationship between the level of knoeledge and acne vulgaris treatment behavior with a significance value (p,001)<0,05.
Analisis Efektivitas Biaya (Cost Effectiveness Analysis) Penggunaan Antibiotik Seftriakson Dan Sefotaksim Pada Pasien Infeksi Saluran Kemih Di Rsd Dr. A. Dadi Tjokrodipo Bandar Lampung Koernia Wahidah, Lilik; Tri Wahyuni, Novita; Andinni, Aulia
JFL : Jurnal Farmasi Lampung Vol. 12 No. 2 (2023): JFL : Jurnal Farmasi Lampung
Publisher : Program Studi Farmasi-Fakultas Matematika dan Ilmu Pengetahuan Alam-Universitas Tulang Bawang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37090/jfl.v12i2.1262

Abstract

Cost-effectiveness analysis is defined as an analysis to identify, measure and compare significant costs and their consequences of alternative interventions. Antibiotics are a group of drugs most often used to treat infectious diseases. Ceftriaxone and cefotaxime are the main options for treating UTI. Urinary Tract Infection (UTI) is a disease with conditions where there are very large numbers of microorganisms in the urine and can cause infection in the urinary tract. This study was designed to analyze the cost-effectiveness of ceftriaxone and cefotaxime treatment for inpatient urinary tract infections at dr. A. Dadi Tjokrodipo. The method used is descriptive with a retrospective pharmacoeconomic analysis approach. The sampling technique was purposive sampling and sampling 92 patient. The research results show characteristics based on sex most are female as much as 55 (60%), based on age ≥56 years in 35 patients (38%), and the highest length of hospitalization was 3 days in 45 patients (49%). The most widely used profile of antibiotic drug use in patients with urinary tract infections was cefotaxime with a total of 64 patients (70%). The average cost for each type of drug therapy from ceftriaxone is 735,117 and sefotaxime is 742,178. Ceftriaxone has the highest percentage of therapeutic effectiveness at 86% compared to cefotaxime at 71%. Antibiotics that are more cost effective are ceftriaxone compared to cefotaxime with an ACER calculation of 78.455. Keywords: Cost Effectiveness Analysis, Urinary Tract Infections, Ceftriaxone, Cefotaxime
Co-Authors Allesia, Eci Andinni, Aulia Lilik Koernia Wahidah Novita Sari